Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 18108
Country/Region: Mozambique
Year: 2016
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USDOD
Total Funding: $2,094,727 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $58,363
Care: Pediatric Care and Support (PDCS) $20,596
Prevention: HIV Testing and Counseling (HVCT) $253,398
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $5,426
Treatment: Adult Treatment (HTXS) $1,642,665
Treatment: Pediatric Treatment (PDTX) $114,279
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 14,499
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 21,263
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,124
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 750
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 37,636
HTC_TST_DSD Service Delivery Point (Community): Other 2017 12,344
HTC_TST_DSD Service Delivery Point (Facility): Outpatient 2017 19,906
HTC_TST_DSD Service Delivery Point (Facility): PMTCT 2017 2,767
HTC_TST_DSD Service Delivery Point (Facility): TB Clinics 2017 973
HTC_TST_DSD Service Delivery Point (Facility): VCT 2017 1,646
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2017 35,762
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2017 1,874
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2017 37,636
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,084
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,534
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Female 2017 80
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Male 2017 53
PMTCT_ART_DSD New on ART 2017 111
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,767
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2017 124
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID_DSD Sum of Infant Age disaggregates 2017 124
PMTCT_STAT_DSD By: Number of new positives identified 2017 138
PMTCT_STAT_DSD Number of new ANC and L&D clients 2017 2,767
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 2,767
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2017 138
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 191
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 127
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 335
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 335
TB_SCREENDX_DSD Screen Result: Screened Positive for TB 2017 422
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Female 2017 1,382
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Male 2017 1,957
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Female 2017 106
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Male 2017 70
TB_SCREENDX_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 3,515
TB_SCREENDX_DSD [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 703
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 562
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 141
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 382
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 20
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 254
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 13
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 669
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2017 669
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2017 4,607
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2017 6,524
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2017 352
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2017 235
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2017 11,718
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2017 11,131
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2017 587
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2017 11,718
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2017 26
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2017 2,503
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2017 39
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2017 906
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,474
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2017 3,474
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 26
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,503
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,002
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 39
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 31
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 906
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 725
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,779
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 3,474